GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unjha Formulations Ltd (BOM:531762) » Definitions » Days Sales Outstanding

Unjha Formulations (BOM:531762) Days Sales Outstanding : 30.77 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Unjha Formulations Days Sales Outstanding?

Unjha Formulations's average Accounts Receivable for the three months ended in Dec. 2023 was ₹18.7 Mil. Unjha Formulations's Revenue for the three months ended in Dec. 2023 was ₹55.5 Mil. Hence, Unjha Formulations's Days Sales Outstanding for the three months ended in Dec. 2023 was 30.77.

The historical rank and industry rank for Unjha Formulations's Days Sales Outstanding or its related term are showing as below:

BOM:531762' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.54   Med: 32.48   Max: 43.49
Current: 35.93

During the past 13 years, Unjha Formulations's highest Days Sales Outstanding was 43.49. The lowest was 21.54. And the median was 32.48.

BOM:531762's Days Sales Outstanding is ranked better than
83.38% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.15 vs BOM:531762: 35.93

Unjha Formulations's Days Sales Outstanding declined from Dec. 2022 (58.90) to Dec. 2023 (30.77).


Unjha Formulations Days Sales Outstanding Historical Data

The historical data trend for Unjha Formulations's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unjha Formulations Days Sales Outstanding Chart

Unjha Formulations Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.76 42.85 38.98 21.54 24.21

Unjha Formulations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.90 33.74 25.45 35.82 30.77

Competitive Comparison of Unjha Formulations's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unjha Formulations's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Unjha Formulations's Days Sales Outstanding falls into.



Unjha Formulations Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Unjha Formulations's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (6.963 + 10.488) / 2 ) / 131.537*365
=8.7255 / 131.537*365
=24.21

Unjha Formulations's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (18.697 + 0) / 1 ) / 55.454*365 / 4
=18.697 / 55.454*365 / 4
=30.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Unjha Formulations  (BOM:531762) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Unjha Formulations Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Unjha Formulations's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Unjha Formulations (BOM:531762) Business Description

Traded in Other Exchanges
N/A
Address
Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.

Unjha Formulations (BOM:531762) Headlines

No Headlines